BioSpace News Archive

The pharmacovigilance and drug safety software market is expected to reach US$ 292.97 Mn in 2027 from US$ 160.67 Mn in 2019. The market is estimated to grow with a CAGR of 7.6% from 2020-2027.

Today, the Bladder Cancer Advocacy Network (BCAN) announced the two recipients of its prestigious Bladder Cancer Research Innovation Award.

Awakn Life Sciences Corp. (NEO: AWKN) (Awakn), a biotechnology company with clinical operations developing and delivering psychedelic medicines to better treat addiction, announced that it will undertake a program of clinical research designed to demonstrate the effectiveness for ketamine-assisted psychotherapy against multiple addictions.

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced it will participate in two investor conferences: the BTIG Virtual Biotechnology Conference on August 9th and 10th and the Canaccord Growth Conference on August 11th and 12th.

Castor, a leading provider of clinical trial software, announced today the closing of a $45 million Series B financing round, bringing the company’s total funding to $65 million.

Tessera Therapeutics announced today the appointment of Howard Liang, Ph.D., as President and Chief Financial Officer .

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration has released an update from its U.S. joint venture, ReGenTree LLC, regarding its progress and prospects of a pre-BLA (Biologics License Application) meeting with FDA.

Lumenis Launches MOSES™ HoLEP University to Help Urologists Master the Gold-Standard Laser Treatment for Enlarged Prostate Peer-led global educational platform focuses on the use of award-winning MOSES laser technology

Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced it will host a webcast and conference call to discuss corporate updates and financial results for its first fiscal quarter 2021, ended June 30, 2021.

BioNova to Host the 20 th Annual Regional BioPort Conference to Highlight the Innovation and Growth Potential of Health and Life Sciences